Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
hot flashes
Glycididazole
chemoradiotherapy
,
esophageal neoplasms
,
carcinoma
,
squamous cell carcinoma
Taxane
fallopian tube diseases
,
neoplasms
,
stomach neoplasms
,
carcinoma
,
adenocarcinoma
,
ovarian neoplasms
,
squamous cell carcinoma
,
urologic neoplasms
,
neoplasm metastasis
,
fallopian tube neoplasms
,
squamous cell neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
transitional cell carcinoma
,
uterine cervical neoplasms
,
castration-resistant prostatic neoplasms
,
small cell lung carcinoma
,
glioblastoma
,
gliosarcoma
,
ovarian epithelial carcinoma
,
endometrial neoplasms
,
female genital neoplasms
,
adenocarcinoma of lung
,
urinary bladder neoplasms
,
peritoneal neoplasms
,
neuroendocrine carcinoma
,
chemoradiotherapy
,
recurrence
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lung neoplasms
,
prostatic neoplasms
,
squamous cell carcinoma of head and neck
,
head and neck neoplasms
,
esophageal neoplasms
,
pancreatic neoplasms
,
melanoma
,
triple negative breast neoplasms
,
pancreatic ductal carcinoma
,
esophageal squamous cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use